These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38662300)

  • 1. Clinical and Brain Morphometry Predictors of Deep Brain Stimulation Outcome in Parkinson's Disease.
    Koivu M; Sihvonen AJ; Eerola-Rautio J; Pauls KAM; Resendiz-Nieves J; Vartiainen N; Kivisaari R; Scheperjans F; Pekkonen E
    Brain Topogr; 2024 Apr; ():. PubMed ID: 38662300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
    Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson's disease.
    Zhang F; Wang F; Li W; Wang N; Han C; Fan S; Li P; Xu L; Zhang J; Meng F
    BMC Neurol; 2021 Mar; 21(1):122. PubMed ID: 33731033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SW2-year outcomes of subthalamic deep brain stimulation for idiopathic Parkinson's disease.
    Nunta-Aree S; Sitthinamsuwan B; Boonyapisit K; Pisarnpong A
    J Med Assoc Thai; 2010 May; 93(5):529-40. PubMed ID: 20524438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson's disease: a meta-analysis of randomized controlled trials.
    Tan ZG; Zhou Q; Huang T; Jiang Y
    Clin Interv Aging; 2016; 11():777-86. PubMed ID: 27382262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal dopamine transporter availability and individual clinical course within the 1-year follow-up of deep brain stimulation of the subthalamic nucleus in patients with Parkinson's disease.
    Löser J; Luthardt J; Rullmann M; Weise D; Sabri O; Meixensberger J; Hesse S; Winkler D
    J Neurosurg; 2021 Feb; 135(5):1429-1435. PubMed ID: 33607613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Effects of Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation on Motor Subtypes in Parkinson's Disease.
    Fan S; Liu D; Shi L; Meng F; Fang H; Liu H; Zhang H; Yang A; Zhang J
    World Neurosurg; 2022 Aug; 164():e245-e255. PubMed ID: 35489598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Outcome of Bilateral Subthalamic Nucleus-Deep Brain Stimulation in Advanced Parkinson's Disease Patients: A Prospective Study.
    Tandra S; Ramavath B; Kandadai RM; Jabeen SA; Kannan MA; Borgohain R
    Ann Indian Acad Neurol; 2020; 23(1):54-58. PubMed ID: 32055123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effectiveness of subthalamic deep brain stimulation in Parkinson's disease: A comparative cohort study at 1 year and 5 years.
    Jiang JL; Chen SY; Hsieh TC; Lee CW; Lin SH; Tsai ST
    J Formos Med Assoc; 2015 Sep; 114(9):835-41. PubMed ID: 24103710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
    Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
    Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach.
    Aviles-Olmos I; Kefalopoulou Z; Tripoliti E; Candelario J; Akram H; Martinez-Torres I; Jahanshahi M; Foltynie T; Hariz M; Zrinzo L; Limousin P
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1419-25. PubMed ID: 24790212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
    Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
    Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
    Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
    Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.
    Rughani A; Schwalb JM; Sidiropoulos C; Pilitsis J; Ramirez-Zamora A; Sweet JA; Mittal S; Espay AJ; Martinez JG; Abosch A; Eskandar E; Gross R; Alterman R; Hamani C
    Neurosurgery; 2018 Jun; 82(6):753-756. PubMed ID: 29538685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between Iron Distribution in Deep Gray Matter Nuclei Measured by Quantitative Susceptibility Mapping and Motor Outcome After Deep Brain Stimulation in Patients With Parkinson's Disease.
    Zhao W; Yang C; Tong R; Chen L; Chen M; Gillen KM; Li G; Ma C; Wang Y; Wu X; Li J
    J Magn Reson Imaging; 2023 Aug; 58(2):581-590. PubMed ID: 36594513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.